MAINTENANCE TREATMENT WITH LOW-DOSE DECITABINE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Rong Guo, 324045
BLINATUMOMAB FOR HLA LOSS RELAPSE AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, He Huang, 324046
INCIDENCE OF HEMATOLOGICAL MALIGNANCIES AT THE NATIONAL CANCER INSTITUTE IN PERU. A 19 YEARS’ EXPERIENCE.
EHA Library, Jule Vasquez, 324047
OUTCOME OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL
EHA Library, Imen Frikha, 324048
A SINGLE-ARM, OPEN-LABEL PHASE 2 PILOT STUDY OF VYXEOS (CPX-351) IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA.
EHA Library, Bijal D. Shah, 324049
L-ASPARAGINASE HYPERSENSITIVITY AND SURVIVAL RELATIONSHIP IN TURKISH PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMİA PATIENTS TREATED WITH MODIFIED ST. JUDE TOTAL XV TREATMENT PROTOCOL
EHA Library, Selin Aytac, 324050
FERRITIN AS A MARKER FOR PROGNOSIS OF THYROID PATHOLOGY AND FEATURES OF THE AMINO ACIDS PROFILE IN THE LONG-TERM CARE OF CHILDREN WHO HAVE SUFFERED FOR ALL AFTER CHORNOBYL ACCIDENT
EHA Library, Katerina Bruslova, 324051
ACUTE LEUKEMIA AT ALEXANDRIA UNIVERSITY CHILDREN'S HOSPITAL: A SIX YEARS' EXPERIENCE
EHA Library, Yasmine El Chazli, 324052
CYTOGENETIC HETEROGENEITY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND TRANSLOCATION T(12;21)(P13;Q22), TEL/AML1 (ETV6-RUNX1)
EHA Library, Anastasia Athanasiadou, 324053
VALIDATION OF OPTICAL GENOME MAPPING FOR DIAGNOSIS OF ACUTE LEUKAEMIA IN PEDIATRIC PATIENTS
EHA Library, Elena García Sánchez, 324054
MANAGEMENT AND MORTALITY OF ACUTE LEUKEMIA DURING COVID-19 PANDEMIC: 8-MONTH FOLLOW-UP AT A SINGLE INSTITUTION IN PERU.
EHA Library, Jule Vasquez, 324055
THE IMPACT OF RISK STRATIFICATION BY EARLY BONE-MARROW RESPONSE IN CHILDHOOD T- ACUTE LYMPHOBLASTIC LEUKAEMIA (A SINGLE INSTITUTION EXPERIENCE IN AZIZA OTHMANA HOSPITAL, TUNIS, TUNISIA).
EHA Library, Ben Abdennebi Yosr, 324056
L-ASPARAGINASE ASSOCIATED ACUTE PANCREATITIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Hale Ören, 324057
ACUTE LYMPHOBLASTIC LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS HEMATOLGY DEPARTMENT EXPERIENCE OF AZIZA OTHMANA HOSPITAL
EHA Library, Bahri Marwa, 324058
L’ASPARAGINASE ALLERGIC REACTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Sabrine Mekni, 324059
ACUTE LYMPHOBLASTIC LEUKEMIA : A DECADE OF MONOCENTRIC EXPERIENCE IN MOROCCO
EHA Library, Siham Ahchouch, 324060
SEVERE HAEMOPHILIA A DIAGNOSED IN A CHILD WITH ALL: FIRST REPORT IN GREECE
EHA Library, Maria Ioannidou, 324061
B-ACUTE LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA WITH ATYPICAL CLINICOPATHOLOGICAL/GENETIC FEATURES
EHA Library, Dina Sameh Soliman, 324062
PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PRESENTED AS CHOLESTATIC JAUNDICE IN A 3-YEAR- OLD BOY
EHA Library, Eleni Thomaidou, 324063
BLINATUMOMAB FOR THE TREATMENT OF ADULT RELAPSED/REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER REAL-LIFE EXPERIENCE OVER TWO YEARS
EHA Library, Alexandra Elena Ghiaur, 324064
ARGENTINE REAL WORLD DATA EXPERIENCE ON GENE MUTATION PROFILING PANELS IN ACUTE MYELOID LEUKEMIA
EHA Library, Marco Lincango-Yupanki, 324065
IDENTIFICATION AND VALIDATION OF A SUBSET OF CANDIDATE FDA-APPROVED DRUGS FOR REPURPOSING IN HOXA EXPRESSING AML
EHA Library, Kate Butcher, 324066
DUAL ROLES FOR PROTEOSTATIC TARGETING IN ACUTE MYELOID LEUKAEMIA
EHA Library, William Grey, 324067
MIRNA EXPRESSION IN ADULT ACUTE MYELOID LEUKAEMIA: BIOMARKERS FOR RISK SUBGROUPS?
EHA Library, Elliott Brown, 324068
NILOTINIB INHIBITS INFLAMMATION IN ACUTE MYELOID LEUKEMIA
EHA Library, Jose Luis Marin-Rubio, 324069
SYNERGISTIC EFFECTS OF A NOVEL COMBINATION OF CLADRIBINE AND CHIDAMIDE ON CELL PROLIFERATION AND APOPTOSIS OF ACUTE MYELOID LEUKEMIA
EHA Library, Zheng Ge, 324070
A CASE OF IDH1 MUTATED AML IN AN ADULT PATIENT AFFECTED BY OLLIER DISEASE, BIOLOGICAL SPECULATIONS AND CLINICAL IMPLICATIONS
EHA Library, Giambattista Bertani, 324071
PREDICTIVE FACTORS AFFECTING THERAPY RESPONSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Maria Kolesnikova, 324072
RETROSPECTIVE ASSESSMENT OF TREATMENT PATTERNS AND RESOURCE UTILIZATION FOR PATIENTS NEWLY DIAGNOSED WITH ACUTE MYELOID LEUKEMIA IN CANADA, UK, FRANCE, GERMANY, ITALY, AND SPAIN
EHA Library, Manasee V. Shah, 324073
A PHASE 1A/B DOSE ESCALATION STUDY OF THE MUTATION AGNOSTIC FLT3/BTK INHIBITOR LUXEPTINIB (CG-806) IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, Rafael Bejar, 324074
PROGNOSTIC IMPACT OF MOLECULAR MARKERS IN ELDERLY PATIENTS AFFECTED BY NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: MONOCENTRIC EXPERIENCE
EHA Library, Danilo De Novellis, 324075
FAVOURABLE OUTCOMES WITH ATRA AND ARSENIC VERSUS ATRA AND CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA IN WESTERN AUSTRALIA- A POPULATION-BASED STUDY.
EHA Library, Annalise Martin, 324076
SURVIVAL OUTCOMES AND ADVERSE EVENTS OF IDH1/2 MUTANT AML PATIENTS TREATED WITH IDH1/2 INHIBITORS: A SINGLE INSTITUTIONAL EXPERIENCE
EHA Library, Constantine Logothetis, 324077
SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF MAINTENANCE THERAPIES FOR ADULTS WITH ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION WHO ARE INELIGIBLE FOR HEMATOPOIETIC STEM CELL TRANSPLANT
EHA Library, Beatrice Suero, 324078
KIT D816 MUTATED T(8;21)(Q22;Q22.1) ACUTE MYELOID LEUKEMIA WITH CONCURRENT SYSTEMIC MASTOCYTOSIS SHOWS POOR RESPONSE TO COMMON CHEMOTHERAPY AND TRANSPLANTATION
EHA Library, Wei Zhang, 324079
COVID-19 IN PATIENTS WITH ACUTE LEUKEMIA: THE EXPERIENCE OF A HEMATOLOGICAL CENTER
EHA Library, Alessandra Malato, 324080
PATIENT PREFERENCES FOR MAINTENANCE THERAPY OF ACUTE MYELOID LEUKEMIA: A DISCRETE CHOICE EXPERIMENT SUBANALYSIS OF PATIENTS IN GERMANY AND ITALY
EHA Library, Katelyn Cutts, 324081
ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA: 10 YEARS EXPERIENCE OF A PORTUGUESE SINGLE CENTER.
EHA Library, Marco Dias, 324082
EFFICACY AND SAFETY OF GEMTUZUMAB IN RELAPSED AND REFRACTORY AML IN REAL WORLD PRACTICE
EHA Library, Irina Budaeva, 324083
EVALUATION OF MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH HYPOMETHYLATING AGENTS: A REAL WORLD EXPERIENCE
EHA Library, Eren Gunduz, 324084
REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): A BELGIAN SUBANALYSIS
EHA Library, Leen Stas, 324085
FREQUENCY OF FLT3-ITD AND FLT3-TKD MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
EHA Library, Juliana Lewis, 324086
EUROPEAN GUIDELINES AND REAL-WORLD EVIDENCE OF MAINTENANCE TREATMENTS FOR ADULTS WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION
EHA Library, Moez Ahmed, 324087
PEVOLAM: TRIAL DESIGN FOR A RANDOMIZED PHASE 3 MULTICENTER STUDY COMPARING AZACITIDINE PLUS PEVONEDISTAT VS AZACITIDINE IN OLDER OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Juan Miguel Bergua Burgues, 324088
PHASE 1/2 FIRST IN HUMAN STUDY OF THE MENIN-KMT2A (MLL) INHIBITOR KO-539 IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, Eunice Wang, 324089
CPX-351 IN THERAPHY RELATED ACUTE MYELOID LEUKEMIA AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES: A MULTICENTER REAL-LIFE EXPERIENCE IN YOUNG PATIENTS (<60 YEARS OLD)
EHA Library, Bruno Garibaldi, 324090
IDENTIFYING LEUKEMIA-ASSOCIATED IMMUNOPHENOTYPES IN ACUTE MYELOID LEUKEMIA PATIENTS USING MULTIPARAMETER FLOW CYTOMETRY
EHA Library, Hadeer Rasheed, 324091
JUVENILE MYELOMONOCYTIC LEUKEMIA IN A PATIENT WITH NOONAN SYNDROME AND FAMILIAL MEDITERRANEAN SYNDROME
EHA Library, Davit Babikyan, 324092
IMPACT OF P53 AND BCL2 EXPRESSION ON PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA: A TEN YEAR SINGLE CENTRE STUDY
EHA Library, Laura Mcdonald, 324093
REAL WORLD DATA ON THE USE OF BCL2 INHIBITION IN ACUTE MYELOID LEUKAEMIA; THE IRISH EXPERIENCE
EHA Library, Laura Mcdonald, 324094
FREQUENCY OF AN HP196–197 INSERTION (6BP) IN C/EBPΑ TAD2 REGION IN RUSSIAN POPULATION OF AML PATIENTS COMPARING TO CONTROL COHORTS.
EHA Library, Yana Kozhevnikova, 324095
A PHASE 1 STUDY OF NKX101, AN ALLOGENEIC CAR NATURAL KILLER (NK) CELL THERAPY, IN SUBJECTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS)
EHA Library, Carlos Bachier, 324096
MUTATION SPECTRUM OF FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA AND ITS PROGNOSTIC INDICATIONS IN A CHINESE PATIENT COHORT
EHA Library, SuJun Gao, 324097
A PROSPECTIVE RANDOMIZED COMPARISON OF HIGH-DOSE CYTARABINE AND HIGH-DOSE DAUNORUBICIN IN THE INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA
EHA Library, Eun-Ji Choi, 324098
LIPOSOMAL ANNAMYCIN FOR R/R AML
EHA Library, Robert Shepard, 324099
REAL-LIFE EFFICACY OF FIXED-DOSE HYPOMETHYLATING AGENTS IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE
EHA Library, Tarinee Rungjirajittranon, 324100
CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA: RESULTS OF A TUNISIAN EXPERIENCE
EHA Library, Hend Ben Neji, 324101
T(6;9)(P22;Q34)/DEK-NUP214-POSITIVE ACUTE MYELOID LEUKEMIA IN ADULTS IS A RARE POOR PROGNOSIS SUBTYPE AFFECTING YOUNGER PATIENTS: THE BULGARIAN EXPERIENCE
EHA Library, Gueorgui Balatzenko, 324102
OUTCOME OF TREATING PEDIATRIC LANGERHANS HISTIOCYTOSIS WITH LCH III IN TERTIARY CENTER, SAUDI ARABIA.
EHA Library, Abrar AlMohammadi, 324103
CHILDREN ACUTE PROMYELOCYTIC LEUKEMIA: HEMATOLOGY DEPARTMENT EXPERIENCE AT AZIZA OTHMANA HOSPITAL
EHA Library, Rym Jaidi, 324104
ALL-TRANS RETINOIC ACID INDUCED MYOCARDITIS AS PART OF DIFFERENTIATION SYNDROME: A CASE REPORT AND LITERATURE REVIEW
EHA Library, Na Kim, 324105
THERAPY-RELATED MYELOID NEOPLASMS: A DESCRIPTIVE ANALYSIS AT A SINGLE INSTITUTION
EHA Library, BEATRIZ MERCHAN MUÑOZ, 324106
TAGRAXOFUSP AS FIRST-LINE TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). A CASE REPORT
EHA Library, Clara Navajas Laguna, 324107
TWO CASE REPORT: CONCURRENT CROHN'S DISEASE AND MYELODYSPLASTIC SYNDROME OR ACUTE LEUKEMIA
EHA Library, Zaineb Mlayah, 324108
THE CORRELATION BETWEEN SKIN RESPONSE AND BLOOD INVOLVEMENT WITH MOGAMULIZUMAB
EHA Library, Pietro Quaglino, 324109
CAR-T CELL THERAPY FOR PEOPLE WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A COCHRANE SYSTEMATIC REVIEW
EHA Library, Moritz Ernst, 324110
RELATIONSHIP BETWEEN GENETIC ABERRATIONS IN THE 17P13/TP53 LOCUS AND IMMUNOHISTOCHEMICAL PROTEIN P53 EXPRESSION IN TUMOR CELLS OF DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Maria Sarpova, 324111
RELATIONSHIP BETWEEN PAKT1, PSYK PROTEINS CO-EXPRESSION AND SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Elena Vaneeva, 324112
ABNORMAL AND COMPLEX KARYOTYPE IS FREQUENT ON ROUTINE KARYOTYPING ON PRIMARY TISSUE IN PATIENTS WITH DIFFUSE LARGE B-CELL AND TRANSFORMED LYMPHOMA BUT DOES NOT INFLUENCE CLINICAL OUTCOMES
EHA Library, Ray Mun Koo, 324113
ESCALADE: ACALABRUTINIB + RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE (R-CHOP) IN UNTREATED NON-GERMINAL CENTER B-CELL–LIKE (NON-GCB) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
EHA Library, Laurie Sehn, 324114
BENDAMUSTINE IS A FAVORABLE LYMPHODEPLETING CHEMOTHERAPY REGIMEN PRIOR TO CAR T CELLS IMMUNOTHERAPY AS FLUDARABINE
EHA Library, Peihao Zheng, 324115
DISPARITIES IN LYMPHOMA SURVIVORSHIP ACCORDING TO SOCIO-DEMOGRAPHIC FACTORS; SINGLE CENTER RETROSPECTIVE STUDY IN A COHORT OF 253 DLBCL PATIENTS TREATED WITH RCHOP
EHA Library, Emmanouil Spanoudakis, 324116
OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA AFTER HIGH-DOSE METHOTREXATE FOLLOWED BY CONSOLIDATION WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE: AN 8-YEAR COHORT STUDY
EHA Library, Pokpong Piriyakhuntorn, 324117
NEUTROPHIL/LYMPHOCYTE RATIO (NLR) ITS A WORSE PROGNOSIS FACTOR IN OVERALL SURVIVAL IN LARGE B CELL LYMPHOMA (DLBCL). EXPERIENCE IN HEMATOLOGY CENTER IN NORTHEAST OF MEXICO
EHA Library, Guillermo Sotomayor Duque, 324118
HEALTH-RELATED QUALITY OF LIFE EFFECT OF MOGAMULIZUMAB BY PATIENT BLOOD INVOLVEMENT
EHA Library, Pier Luigi Zinzani, 324119
PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) - LOTIS-5
EHA Library, Carmelo Carlo-Stella, 324120
BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)
EHA Library, Nancy L. Bartlett, 324121
SAFETY AND FEASIBILITY OF HIGH DOSE CHEMOTHERAPY WITH PBSC RESCUE AND ASCT CONSOLIDATION IN PCNSL: A SINGLE CENTER EXPERIENCE
EHA Library, Emanuele Ravano, 324122
ACUTE TOXICITY OF R-CHOP PROTOCOL IN THE TREATMENT OF NON-HODGKIN'S LYMPHOMA : ABOUT 551 CYCLES
EHA Library, Emna Ines Saidi, 324123
LONG-TERM ANALYSES FROM L-MIND, A PHASE II STUDY OF TAFASITAMAB (MOR208) COMBINED WITH LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
EHA Library, Johannes Düll, 324124
MANUFACTURING COMMERCIAL AXICABTAGENE CILOLEUCEL FOR EUROPEAN PATIENTS: A 2-YEAR RETROSPECTIVE ANALYSIS
EHA Library, Louis van de Wiel, 324125
RELATIONSHIP BETWEEN PAKT1, PSYK PROTEINS CO-EXPRESSION AND SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Elena Vaneeva, 324126
ТHE PROGNOSTIC ROLE OF PD-L1 PROTEIN EXPRESSION IN A COMBINED MODEL FOR PREDICTION OF THE SURVIVAL OF DIFFUSE LARGE B CELL LYMPHOMA PATIENTS
EHA Library, Svetlana Samarina, 324127
COPANLISIB IN COMBINATION WITH RITUXIMAB-BENDAMUSTINE IN PATIENTS WITH RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTRIC PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)
EHA Library, Mattia Novo, 324128
RADIOTHERAPY FOR SYSTEMIC B-CELL LYMPHOMA WITH CUTANEOUS INFILTRATION: IS IT WORTHY?
EHA Library, Ana Luisa Martins, 324129
DOSE-ADJUSTED EDOCH-RITUXIMAB IN ELDERLY PATIENTS WITH HIGH GRADE DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, BEATRIZ MERCHAN MUÑOZ, 324130
FRONT-MIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY COMPARING EFFICACY AND SAFETY OF R-CHOP + TAFASITAMAB + LENALIDOMIDE VS R-CHOP ALONE FOR NEWLY-DIAGNOSED HIGH-RISK DLBCL
EHA Library, Umberto Vitolo, 324131
PRIMARY GASTRIC LARGE B CELL LYMPHOMA:EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX
EHA Library, Maha Charfi, 324132
FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION (SGN35-032, TRIAL IN PROGRESS)
EHA Library, Deepa Jagadeesh, 324133
IMPLICATIONS OF IMMUNOMODULATORY MEDICATIONS IN COVID-19 INFECTED HEMATOLOGICAL MALIGNANCY PATIENTS IN QATAR
EHA Library, Afaf Al Battah, 324134
TREATMENT PATTERN AND PROGNOSIS ANALYSIS OF NEWLY DIAGNOSED T / NK CELL LYMPHOMA PATIENTS
EHA Library, Naoki Takahashi, 324135
SUCCESSFUL TREATMENT BRENTUXIMAB VEDOTIN OF CD30-NEGATIVE ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: CASE REPORT
EHA Library, Elena Lepik, 324136
DIFFUSE LARGE B-CELL LYMPHOMA AND HIGH-GRADE B-CELL LYMPHOMA: THERAPEUTIC RESPONSE - UNICENTRIC RETROSPECTIVE DESCRIPTIVE ANALYSIS
EHA Library, Bianca Castro, 324137
MYD88 EXPRESSION IN PRIMARY AND SECONDARY CNS LYMPHOMAS
EHA Library, berrin balik aydin, 324138
SUCCESSFUL MANAGEMENT OF EARLY CENTRAL NERVOUS SYSTEM RELAPSE IN A PATIENT WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA
EHA Library, Rostyslav Lozynskyy, 324139
BELINOSTAT IS WELL TOLERATED AND EFFICACIOUS IN A PATIENT WITH EARLY RELAPSED PERIPHERAL T-CELL LYMPHOMA: A CASE REPORT.
EHA Library, Michele Cimminiello, 324140
INCIDENTAL DIAGNOSIS OF BURKITT LYMPHOMA ON CECAL APPENDIX: CASE REPORT AND LITERATURE REVIEW
EHA Library, Sonia Mallano, 324141
INHIBITORS IN MILD HAEMOPHILIA A: EXPERIENCE OF A SINGLE SPANISH CENTER
EHA Library, Manuel Rodríguez Lopez, 324142
ANALYSIS OF SURVIVAL IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY TYPE B USING A LARGE, DEIDENTIFIED US ELECTRONIC HEALTH RECORD DATABASE
EHA Library, Amanda Wilson, 324143
TRANSTHORACIC AORTIC VALVE IMPLANTATION (TAVI) IN HEMOPHILIA
EHA Library, Manuel Rodríguez Lopez, 324144

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings